ARTICLE | Financial News
Stemline proposes follow-on
October 21, 2013 7:00 AM UTC
Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y. Business: Cancer Date announced: 10/17/13 Type: Follow-on To be raised: Up to $90 million Shares: TBD Price prior: $37.99 Underwriters: JPMorga...